In Vitro Diagnostics (IVD) Quality Control Market

In Vitro Diagnostics (IVD) Quality Control Market by Application (Immunoassay, Molecular Diagnostics, Microbiology, Hemostasis, Hematology), Source (Serum, Whole Blood, Urine), Type (Instrument Specific, Third Party Control) - Global Forecast to 2022

Report Code: MD 4180 Jul, 2017, by marketsandmarkets.com

[219 Pages Report] The global IVD quality control market is expected to reach USD 1.04 billion by 2022, at a CAGR of 3.5% from 2017 to 2022. Growth in the global IVD quality controls market is mainly driven by factors such as the increasing number of accredited clinical laboratories and growing adoption of third party quality controls to ensure unbiased test results. Moreover, the increasing use of multi-analyte controls and increasing focus of key players on emerging countries are creating new growth opportunities for this market. The IVD quality controls market is expanding with the emergence of new products and applications. These IVD quality controls being used in many applications such as clinical chemistry, immunochemistry, hematology, molecular diagnostics, coagulation & hemostasis, microbiology, and other applications. The base year considered for the study is 2016, and the forecast has been provided for the period between 2017 and 2022.

Market Dynamics

Drivers

  • Increasing number of accredited clinical laboratories
  • Growing adoption of third-party quality controls
  • Rising demand for external quality assessment (EQA) support

Restraints

  • Additional costs involved in quality control and budget constraints in hospitals and laboratories
  • Unfavorable reimbursement scenario for IVD tests

Opportunities

  • Rising demand for multi-analyte controls

Challenge

  • Stringent product approval process
  • Lack of mandatory regulations for clinical laboratory accreditations in several emerging countries

Growing Adoption Of Third-Party Quality Controls-Drive The Global Ivd Quality Control Market

Either IVD instrument manufacturers or third-party manufacturers produce IVD quality controls. The latter produce two types of quality controls-instrument-specific and independent. Independent controls can be used to detect procedural errors with multiple IVD instruments or reagents. These controls offer various advantages over instrument-specific controls that are linked into a single reagent/calibrator/analyzer system. Independent/third-party controls offer a longer shelf life and allow use of the same control over multiple changes of reagent and calibrator lot numbers, thereby enabling long-term quality control monitoring.

In addition, technological development has resulted in the introduction of multi-analyte multi-instrument controls, which consolidate multiple instrument-specific controls into a single product. This reduces the overall cost by eliminating the need to purchase separate controls for each individual laboratory system/ instrument. The benefits of these controls have played a key role in ensuring their greater adoption among end users.

The following are the major objectives of the study.

  • To define, describe, and forecast the global in vitro diagnostics (IVD) quality control market based on product type, application, end users, and manufacturer type
  • To provide detailed information regarding the major factors influencing growth of the IVD quality control market (drivers, restraints, opportunities, and challenges)
  • To strategically analyze the various segments and sub-segments covered in the study with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the IVD quality control market for stakeholders and provide details about the competitive landscape for market leaders
  • To profile key players in this market and comprehensively analyze their market shares and core competencies1
  • To forecast the market size of the global IVD quality control market with respect to five main regions – North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa
  • To track and analyze competitive developments such as acquisitions, product developments, agreements, partnerships, expansions, and R&D activities in the IVD quality control market

During this research study, major players operating in the IVD quality control market in various regions have been identified, and their offerings, regional presence, and distribution channels have been analyzed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Factiva, along with primary respondents. The entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) pertaining to the market. The figure below shows the breakdown of the primaries on the basis of the company type, designation, and region considered during the research study.

In Vitro Diagnostics (IVD) Quality Control Market

To know about the assumptions considered for the study, download the pdf brochure

The IVD quality control market comprises a network of players involved in the research and product development; raw material supply; component manufacturing; distribution and sale; and post-sales services. Key players considered in the analysis of the IVD quality control market are Bio-Rad Laboratories (US), Thermo Fisher Scientific (US), Randox Laboratories (UK), Roche Diagnostics (Switzerland), Abbott Laboratories (US), Danaher Corporation (US), Siemens Healthcare (Germany), and Sysmex Corporation (Japan)

Major Market Developments

  • Bio-Rad Laboratories (US) launched the Amplichek STI—a Multi-analyte Quality Control in 2017.
  • Randox Laboratories (US) launched the Liquid HbA1c Control, Acusera Parathyroid Hormone (PTH) Control, and Acusera CSF Control in 2016.
  • In 2016, Roche Diagnostics Middle East opened a new training center in Jafza-Jebel Ali, Dubai. The new training center offers training sessions based on medical value, quality control, and accreditation to healthcare professionals in the UAE and the Middle East.

Target Audience

  • IVD product manufacturers
  • Group purchase organizations (GPOs)
  • OEM manufacturers
  • Pathologists and pathology laboratories
  • Distributors of IVD quality control products
  • Hospitals and clinics
  • Healthcare institutions
  • Research institutes
  • Market research and consulting firms
  • Venture capitalists and investors

Report Scope

IVD Quality Control Products Market, By Type

  • Quality Control Products
    • Human Serum/Plasma Based
    • Human Whole Blood Based
    • Human Urine Based
    • Others
  • Data Management Solutions
  • Quality Assurance Services

IVD Quality Controls Market, By Application

  • Clinical Chemistry
  • Immunochemistry
  • Hematology
  • Molecular Diagnostics
  • Coagulation/Hemostasis
  • Microbiology
  • Other Applications

IVD Quality Controls Market, By End User

  • Hospitals
  • Laboratory
  • Research Institutes and Academics
  • Other End Users

IVD Quality Controls Market, By Manufacturer type

  • Instrument Manufacturer Control
  • Independent Manufacturer Control
    • Third Party Control
    • Instrument Specific Control

IVD Quality Controls Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLA)
  • Middle East and Africa

Critical questions which the report answers

  • What are new application areas which the IVD quality controls companies are exploring?
  • Which are the key players in the market and how intense is the competition?

Available Customizations

Based on the given market data, MarketsandMarkets offers customizations in the reports as per the client’s specific requirements. The available customization options are as follows:

Geographic Analysis

  • Further country-wise breakdown of the Rest of Asia-Pacific IVD market in South Korea, Australia, New Zealand, and other countries based on product

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

The global in vitro diagnostics (IVD) quality controls market is estimated to reach USD 1.04 billion by 2022, growing at a CAGR of 3.5% during the forecast period of 2017 to 2022. This market is mainly driven by the growing number of accredited clinical laboratories across the globe and growing need to ensure the accuracy, reliability of the diagnostic test results. However, extending reach of multi analyte controls over single analyte benefited in long run quality control procedures are creating new opportunities for this market.

IVD Quality controls are products/materials made from various biological components, such as whole blood, serum, plasma, urine, and spinal fluid sourced from human or animal origin.

The IVD quality control market has been segmented, on the basis of product and services. The market is segmented into quality controls, data management solutions and quality assurance services. The market for quality controls segment is expected to grow at the highest CAGR between 2017 and 2022. The increasing availability & demand for technologically advanced quality control materials with greater stability contribute to the rapid growth of the market. Also, the number of accredited clinical laboratories and mandates on these laboratories to perform quality control tests is driving the growth of IVD quality controls market.

The IVD quality control market in APAC is expected to grow at the highest CAGR during the forecast period. The growth of this region is primarily driven by the rapid growth in the number of accredited laboratories and increasing use of quality control products by the clinical laboratories in this region

In Vitro Diagnostics (IVD) Quality Control Market

Applications in clinical chemistry, immunochemistry, hematology, molecular diagnostics, coagulation & hemostasis, microbiology, and other applications drive the growth of IVD quality control market

Immunochemistry

The increasing adoption of multi-analyte controls is a major factor driving growth of this market, as multi-analyte controls help reduce the range of quality controls required to achieve accurate results from immunoassay tests. To improve the power of quality control programs, laboratories are looking to consolidated controls used for integrated immunoassay platforms as well as to ensure high throughput without compromising on accuracy. The use of consolidated controls allows laboratories to reduce the number of controls required while minimizing cost.

Clinical Chemistry

Clinical chemistry is the application of chemical, molecular, and cellular concepts & techniques to understand and evaluate human health. In clinical chemistry analysis, quality control procedures help identify errors and provide control solutions to correct them. They also confirm the accuracy of results.

Hematology

Multi-analyte hematology quality controls help increase the efficiency of laboratories in blood testing. Some independent manufacturers provide third-party quality control solutions for hematology analyzers. For instance, Randox Laboratories (UK) provides the Acusera hematology control for Sysmex hematology analyzers. The growing demand for multi-analyte third-party hematology quality controls is expected to drive growth of this market segment during the forecast period.

Molecular Diagnostics

Molecular diagnostic tests are performed to access the biological makeup of an individual/ organism at the genetic level to identify predisposition toward a particular disease or condition and diagnose it. Currently, molecular test systems are very complex and expensive. Compared to other laboratory tests, the quality control practices for molecular diagnostic tests are facing challenges such as new and developing technologies, high expectations of accuracy for once-in-a-lifetime genetic tests, and a lack of quality control materials. This is leading to the development of suitable quality assurance programs for molecular diagnostic tests performed in labs.

Coagulation & Hemostasis

Blood coagulation disorders include disorders showing lack of blood coagulation factors such as prothrombin, fibrinogen, calcium factor, and antihemophilic factors. Specific tests are required to diagnose and treat these disorders. Various tests are performed in coagulation laboratories for the correct diagnosis and safe management of patients with bleeding and thrombotic disorders. A laboratory error may lead to misdiagnosis, resulting in adverse clinical effects. Therefore, adequate quality control procedures are required to ensure accurate and precise patient test results.

Microbiology

Clinical microbiology testing is indispensable for identifying bacterial, fungal, and parasitic infections. It is also helpful in the clinical management of patients. It is essential that test reports are relevant, reliable, timely, and interpreted correctly. Quality control and quality assurance in microbiology ensure diagnostic test accuracy and positive patient outcomes.

Critical questions the report answers:

  • Where will all these developments take the industry in the mid to long term?
  • What are the upcoming industry applications for IVD quality control products?

The unfavorable reimbursement scenario for IVD tests, additional costs involved in the quality control process, and budget constraints in hospitals and laboratories are are major factor restraining the growth of the market. Setting up a quality control process in a clinical laboratory requires significant investment. Laboratories also need to maintain dedicated personnel to manage the QC system. Moreover, QC procedures incur similar costs, regardless of the volume of tests performed. Hence, the cost of adopting QC procedures is very high for clinical laboratories working with low volumes of diagnostic tests. This, coupled with budgetary constraints in many hospitals and laboratories in the developed and developing economies, is expected to result in the lower adoption of quality control practices during the forecast period.

Key players in the market include Bio-Rad Laboratories (US), Thermo Fisher Scientific (US), Randox Laboratories (UK), Roche Diagnostics (Switzerland), Abbott Laboratories (US), Danaher Corporation (US), Siemens Healthcare (Germany), and Sysmex Corporation (Japan). These players are increasingly undertaking mergers and acquisitions, and product launches to develop and introduce new IVD quality controls in the market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 18)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 22)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 29)

4 Premium Insights (Page No. - 35)
    4.1 IVD Quality Controls: Market Overview (2017-2022)
    4.2 Asia-Pacific: IVD Quality Controls Market, By Type
    4.3 Geographic Snapshot of the IVD Quality Controls Market
    4.4 Geographic Mix: IVD Quality Controls Market
    4.5 IVD Quality Controls Market: Developing vs Developed Countries

5 Market Overview (Page No. - 39)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Market Drivers
                    5.2.1.1 Increasing Number of Accredited Clinical Laboratories
                    5.2.1.2 Growing Adoption of Third-Party Quality Controls
                    5.2.1.3 Rising Demand for External Quality Assessment (EQA) Support
           5.2.2 Market Restraints
                    5.2.2.1 Additional Costs Involved in Quality Control and Budget Constraints in Hospitals and Laboratories
                    5.2.2.2 Unfavorable Reimbursement Scenario for IVD Tests
           5.2.3 Market Opportunities
                    5.2.3.1 Rising Demand for Multi-Analyte Controls
           5.2.4 Market Challenges
                    5.2.4.1 Stringent Product Approval Process
                    5.2.4.2 Lack of Mandatory Regulations for Clinical Laboratory Accreditations in Several Emerging Countries

6 Industry Insights (Page No. - 47)
    6.1 Introduction
    6.2 Industry Trends
           6.2.1 Growing Adoption of Third-Party Quality Controls
           6.2.2 Increasing Focus of Customers on the Use of External Quality Assurance Support From Manufacturers
           6.2.3 Lyophilized Or Freeze-Dried Controls
           6.2.4 Trends on Analyte Source: Human vs Animal Origin
    6.3 Porter’s Five Force Analysis
           6.3.1 Threat of New Entrants
           6.3.2 Threat of Substitutes
           6.3.3 Bargaining Power of Suppliers
           6.3.4 Bargaining Power of Buyers
           6.3.5 Intensity of Competitive Rivalry
    6.4 Regulatory Analysis
           6.4.1 North America
                    6.4.1.1 U.S.
                    6.4.1.2 Canada
           6.4.2 Europe
           6.4.3 Asia-Pacific
                    6.4.3.1 Japan
                    6.4.3.2 China
                    6.4.3.3 India

7 Global IVD Quality Controls Market, By Product and Service (Page No. - 55)
    7.1 Introduction
    7.2 Quality Control Products
           7.2.1 Serum/Plasma-Based Controls
           7.2.2 Whole Blood-Based Controls
           7.2.3 Urine-Based Controls
           7.2.4 Other Source-Based IVD Quality Controls
    7.3 Data Management Solutions
    7.4 Quality Assurance Services

8 Global IVD Quality Controls Market, By Application (Page No. - 67)
    8.1 Introduction
    8.2 Immunochemistry/Immunoassay
    8.3 Clinical Chemistry
    8.4 Hematology
    8.5 Molecular Diagnostics
    8.6 Coagulation & Hemostasis
    8.7 Microbiology
    8.8 Other Applications

9 Global IVD Quality Controls Market, By Manufacturer Type (Page No. - 77)
    9.1 Introduction
    9.2 Third-Party Control Manufacturers
           9.2.1 Independent Controls
           9.2.2 Instrument-Specific Controls
    9.3 Original Equipment Manufacturers (OEMS)

10 Global IVD Quality Controls Market, By End User (Page No. - 83)
     10.1 Introduction
     10.2 Hospitals
     10.3 Clinical Laboratories
     10.4 Academic & Research Institutes
     10.5 Other End Users

11 Global IVD Quality Control Market, By Region (Page No. - 90)
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 France
             11.3.3 U.K.
             11.3.4 Italy
             11.3.5 Spain
             11.3.6 Rest of Europe (RoE)
     11.4 Asia-Pacific
             11.4.1 Japan
             11.4.2 China
             11.4.3 India
             11.4.4 Rest of Asia-Pacific (RoAPAC)
     11.5 Latin America
             11.5.1 Brazil
             11.5.2 Mexico
             11.5.3 Rest of Latin America
     11.6 Middle East and Africa

12 Competitive Landscape (Page No. - 147)
     12.1 Introduction
     12.2 Market Share Analysis
     12.3 Ranking for External Quality Assessment Schemes (EQAs)
     12.4 Competitive Leadership Mapping
             12.4.1 Visionary Leaders
             12.4.2 Innovators
             12.4.3 Emerging Companies
             12.4.4 Dynamic Differentiators
     12.5 Business Strategies Excellence
     12.6 Strength of Product Portfolio

*Top 25 Companies Analyzed for This Study are - Bio-Rad Laboratories, Inc. (U.S.), Randox Laboratories Ltd. (U.K.), Seracare Life Sciences Inc. (U.S.), Fortress Diagnostics (U.K.), and Thermo Fisher Scientific Inc. (U.S.), Technopath Clinical Diagnostics (Ireland), Sysmex Corporation (Japan), Quantimetrix Corporation (U.S.), Weqas (U.K.), Audit Microcontrols, Inc. (U.S.), and Streck Inc. (U.S.), Sun Diagnostics, LLC (U.S.), Sero as (Norway), Abbott Laboratories, Inc. (U.S.), Helena Laboratories (U.S.), Danaher Corporation (U.S.), Eurocell Diagnostics (France), Agappe Diagnostics Ltd. (India), Australian Scientific Enterprise Pty. Ltd. (Australia), Transasia Bio Medicals Ltd. (India), Pointe Scientific Inc. (U.S.), and Zeptometrix Corporation (U.S.) , Siemens Healthineers (Germany), Roche Diagnostics (Switzerland), and Ortho Clinical Diagnostics, Inc. (U.S.)

13 Company Profiles (Page No. - 154)
(Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key Relationships)*
     13.1 Bio-Rad Laboratories, Inc.
     13.2 Roche Diagnostics
     13.3 Abbott Laboratories Inc.
     13.4 Thermo Fisher Scientific, Inc.
     13.5 Helena Laboratories
     13.6 Seracare Life Sciences, Inc.
     13.7 Sero as
     13.8 Randox Laboratories Ltd.
     13.9 Siemens AG
     13.10 Technopath Clinical Diagnostics
     13.11 Ortho Clinical Diagnostics, Inc.
     13.12 Sun Diagnostics, LLC
     13.13 Sysmex Corporation
     13.14 Danaher Corporation

*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key Relationships Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 208)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.4 Introducing RT: Real-Time Market Intelligence
     14.5 Available Customizations
     14.6 Related Reports
     14.7 Author Details


List of Tables (162 Tables)

Table 1 Global IVD Quality Controls Market Snapshot
Table 2 Market Drivers: Impact Analysis
Table 3 Number of Accredited Medical Laboratories in Europe, 2011-2014
Table 4 Number of Accredited Medical Laboratories in Japan, Australia, India, and Canada, June 2011-March 2015
Table 5 Market Restraints: Impact Analysis
Table 6 Market Opportunities: Impact Analysis
Table 7 Market Challenges: Impact Analysis
Table 8 U.S.: Classification of Quality Control Material
Table 9 Canada: Classification of IVD Products
Table 10 Accreditation Bodies for Quality Systems for Medical Laboratories in Europe
Table 11 Global IVD Quality Controls Market, By Product & Service, 2015–2022 (USD Million)
Table 12 Global IVD Quality Control Products Market, By Type, 2015–2022 (USD Million)
Table 13 Global IVD Quality Control Products Market, By Country, 2015–2022 (USD Million)
Table 14 Serum/Plasma-Based Quality Controls Offered By Key Market Players
Table 15 Global Serum/Plasma-Based Quality Controls Market, By Country, 2015–2022 (USD Million)
Table 16 Whole Blood-Based Quality Controls Offered By Key Market Players
Table 17 Global Whole Blood-Based Quality Controls Market, By Country, 2015–2022 (USD Million)
Table 18 Urine-Based Quality Controls Offered By Key Market Players
Table 19 Global Urine-Based Quality Controls Market, By Country, 2015–2022 (USD Million)
Table 20 Spinal Fluid-Based Quality Controls Offered By Key Market Players
Table 21 Global Other Source-Based IVD Quality Controls Market, By Country, 2015–2022 (USD Million)
Table 22 Data Management Solutions Offered By Key Market Players
Table 23 Global IVD Quality Control Data Management Solutions Market, By Country, 2015–2022 (USD Million)
Table 24 Quality Assurance Services Offered By Key Market Players
Table 25 Global IVD Quality Assurance Services Market, By Country, 2015–2022 (USD Million)
Table 26 Global IVD Quality Controls Market, By Application, 2015–2022 (USD Million)
Table 27 Global IVD Quality Controls Market for Immunochemistry/Immunoassay, By Country, 2015–2022 (USD Million)
Table 28 Global IVD Quality Controls Market for Clinical Chemistry, By Country, 2015–2022 (USD Million)
Table 29 Global IVD Quality Controls Market for Hematology, By Country, 2015–2022 (USD Million)
Table 30 Global IVD Quality Controls Market for Molecular Diagnostics, By Country, 2015–2022 (USD Million)
Table 31 Global IVD Quality Controls Market for Coagulation & Hemostasis, By Country, 2015–2022 (USD Million)
Table 32 Global IVD Quality Controls Market for Microbiology, By Country, 2015–2022 (USD Million)
Table 33 Global Quality Controls Market for Other Applications, By Country, 2015–2022 (USD Million)
Table 34 Global IVD Quality Controls Market, By Manufacturer Type, 2015–2022 (USD Million)
Table 35 Global Third-Party Controls Market, By Country, 2015–2022 (USD Million)
Table 36 Global Third-Party Controls Market, By Type, 2015–2022 (USD Million)
Table 37 Global Independent Controls Market, By Country, 2015–2022 (USD Million)
Table 38 Global Instrument-Specific Controls Market, By Country, 2015–2022 (USD Million)
Table 39 Global Original Equipment Manufacturers Controls Market, By Country, 2015–2022 (USD Million)
Table 40 Global IVD Quality Controls Market, By End User, 2015–2022 (USD Million)
Table 41 Global IVD Quality Controls Market for Hospitals, By Country, 2015–2022 (USD Million)
Table 42 Global IVD Quality Controls Market for Clinical Laboratories, By Country, 2015–2022 (USD Million)
Table 43 Global IVD Quality Controls Market for Research & Academic Institutes, By Country, 2015–2022 (USD Million)
Table 44 Global IVD Quality Controls Market for Other End Users, By Country, 2015–2022 (USD Million)
Table 45 Global IVD Quality Controls Market Size, By Region, 2015–2022 (USD Million)
Table 46 Global IVD Quality Controls Market Size, By Country, 2015–2022 (USD Million)
Table 47 North America: IVD Quality Controls Market Size, By Country, 2015–2022 (USD Million)
Table 48 North America: IVD Quality Controls Market Size, By Product and Service, 2015–2022 (USD Million)
Table 49 North America: IVD Quality Control Products Market Size, By Source Type, 2015–2022 (USD Million)
Table 50 North America: IVD Quality Controls Market Size, By Application, 2015–2022 (USD Million)
Table 51 North America: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 52 North America: IVD Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 53 U.S.: Macroeconomic Indicators
Table 54 U.S.: IVD Quality Controls Market Size, By Product & Service, 2015–2022 (USD Million)
Table 55 U.S.: IVD Quality Control Products Market Size, By Source Type, 2015–2022 (USD Million)
Table 56 U.S.: IVD Quality Controls Market Size, By Application, 2015–2022 (USD Million)
Table 57 U.S.: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 58 U.S.: IVD Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 59 Canada: Macroeconomic Indicators
Table 60 Canada: IVD Quality Controls Market Size, By Product & Service, 2015–2022 (USD Million)
Table 61 Canada: IVD Quality Control Products Market Size, By Source Type, 2015–2022 (USD Million)
Table 62 Canada: IVD Quality Controls Market Size, By Application, 2015–2022 (USD Million)
Table 63 Canada: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 64 Canada: IVD Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 65 Europe: IVD Quality Controls Market Size, By Country, 2015–2022 (USD Million)
Table 66 Europe: IVD Quality Controls Market Size, By Product and Service, 2015–2022 (USD Million)
Table 67 Europe: IVD Quality Control Products Market Size, By Source Type, 2015–2022 (USD Million)
Table 68 Europe: IVD Quality Controls Market Size, By Application, 2015–2022 (USD Million)
Table 69 Europe: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 70 Europe: IVD Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 71 Germany: Macroeconomic Indicators
Table 72 Germany: IVD Quality Controls Market Size, By Product and Service, 2015–2022 (USD Million)
Table 73 Germany: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 74 Germany: IVD Quality Controls Market Size, By Application, 2015–2022 (USD Million)
Table 75 Germany: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 76 Germany: IVD Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 77 France: Macroeconomic Indicators
Table 78 France: IVD Quality Controls Market Size, By Product and Service, 2015–2022 (USD Million)
Table 79 France: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 80 France: IVD Quality Controls Market Size, By Application, 2015–2022 (USD Million)
Table 81 France: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 82 France: IVD Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 83 U.K.: Macroeconomic Indicators
Table 84 U.K.: IVD Quality Controls Market Size, By Product & Services, 2015–2022 (USD Million)
Table 85 U.K.: IVD Quality Control Products Market Size, By Source Type, 2015–2022 (USD Million)
Table 86 U.K.: IVD Quality Controls Market Size, By Application, 2015–2022 (USD Million)
Table 87 U.K.: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 88 U.K.: IVD Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 89 Italy: Macroeconomic Indicators
Table 90 Italy: IVD Quality Controls Market Size, By Product & Service, 2015–2022 (USD Million)
Table 91 Italy: IVD Quality Control Products Market Size, By Source Type, 2015–2022 (USD Million)
Table 92 Italy: IVD Quality Controls Market Size, By Application, 2015–2022 (USD Million)
Table 93 Italy: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 94 Italy: IVD Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 95 Spain: Macroeconomic Indicators
Table 96 Spain: IVD Quality Controls Market Size, By Product and Service, 2015–2022 (USD Million)
Table 97 Spain: IVD Quality Control Products Market Size, By Source Type, 2015–2022 (USD Million)
Table 98 Spain: IVD Quality Controls Market Size, By Application, 2015–2022 (USD Million)
Table 99 Spain: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 100 Spain: IVD Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 101 RoE: IVD Quality Controls Market Size, By Product and Service, 2015–2022 (USD Million)
Table 102 RoE: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 103 RoE: IVD Quality Controls Market Size, By Application, 2015–2022 (USD Million)
Table 104 RoE: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 105 RoE: IVD Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 106 APAC: IVD Quality Controls Market Size, By Country, 2015–2022 (USD Million)
Table 107 APAC: IVD Quality Controls Market Size, By Product and Service, 2015–2022 (USD Million)
Table 108 APAC: IVD Quality Control Products Market Size, By Source Type, 2015–2022 (USD Million)
Table 109 APAC: IVD Quality Controls Market Size, By Application, 2015–2022 (USD Million)
Table 110 APAC: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 111 APAC: IVD Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 112 Japan: Macroeconomic Indicators
Table 113 Japan: IVD Quality Controls Market Size, By Product and Service, 2015–2022 (USD Million)
Table 114 Japan: IVD Quality Control Products Market Size, By Source Type, 2015–2022 (USD Million)
Table 115 Japan: IVD Quality Controls Market Size, By Application, 2015–2022 (USD Million)
Table 116 Japan: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 117 Japan: IVD Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 118 China: Macroeconomic Indicators
Table 119 China: IVD Quality Controls Market Size, By Product and Service, 2015–2022 (USD Million)
Table 120 China: IVD Quality Control Products Market Size, By Source Type, 2015–2022 (USD Million)
Table 121 China: IVD Quality Controls Market Size, By Application, 2015–2022 (USD Million)
Table 122 China: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 123 China: IVD Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 124 India: Macroeconomic Indicators
Table 125 India: IVD Quality Controls Market Size, By Product and Service, 2015–2022 (USD Million)
Table 126 India: IVD Quality Control Products Market Size, By Source Type, 2015–2022 (USD Million)
Table 127 India: IVD Quality Controls Market Size, By Application, 2015–2022 (USD Million)
Table 128 India: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 129 India: IVD Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 130 RoAPAC: IVD Quality Controls Market Size, By Product and Service, 2015–2022 (USD Million)
Table 131 RoAPAC: IVD Quality Control Products Market Size, By Source Type, 2015–2022 (USD Million)
Table 132 RoAPAC: IVD Quality Controls Market Size, By Application, 2015–2022 (USD Million)
Table 133 RoAPAC: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 134 RoAPAC: IVD Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 135 Latin America: IVD Quality Controls Market Size, By Country, 2015–2022 (USD Million)
Table 136 Latin America: IVD Quality Controls Market Size, By Product and Service, 2015–2022 (USD Million)
Table 137 Latin America: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 138 Latin America: IVD Quality Controls Market Size, By Application, 2015–2022 (USD Million)
Table 139 Latin America: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 140 Latin America: IVD Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 141 Brazil: Macroeconomic Indicators
Table 142 Brazil: IVD Quality Controls Market Size, By Product and Service, 2015–2022 (USD Million)
Table 143 Brazil: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 144 Brazil: IVD Quality Controls Market Size, By Application, 2015–2022 (USD Million)
Table 145 Brazil: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 146 Brazil: IVD Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 147 Mexico: Macroeconomic Indicators
Table 148 Mexico: IVD Quality Controls Market Size, By Product and Service, 2015–2022 (USD Million)
Table 149 Mexico: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 150 Mexico: IVD Quality Controls Market Size, By Application, 2015–2022 (USD Million)
Table 151 Mexico: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 152 Mexico: IVD Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 153 RoLA: IVD Quality Controls Market Size, By Product and Service, 2015–2022 (USD Million)
Table 154 RoLA: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 155 RoLA: IVD Quality Controls Market Size, By Application, 2015–2022 (USD Million)
Table 156 RoLA: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 157 RoLA: IVD Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)
Table 158 Middle East and Africa: IVD Quality Controls Market Size, By Product and Service, 2015–2022 (USD Million)
Table 159 Middle East and Africa: IVD Quality Control Products Market Size, By Type, 2015–2022 (USD Million)
Table 160 Middle East and Africa: IVD Quality Controls Market Size, By Application, 2015–2022 (USD Million)
Table 161 Middle East and Africa: IVD Quality Controls Market Size, By End User, 2015–2022 (USD Million)
Table 162 Middle East and Africa: IVD Quality Controls Market Size, By Manufacturer Type, 2015–2022 (USD Million)


List of Figures (36 Figures)

Figure 1 Global IVD Quality Controls Market
Figure 2 Research Design
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Global IVD Quality Controls Market, By Product and Service, 2017 vs 2022 (USD Million)
Figure 7 Global IVD Quality Controls Market, By Source, 2017 vs 2022 (USD Million)
Figure 8 Global IVD Quality Controls Market, By Manufacturer Type, 2017 vs 2022 (USD Million)
Figure 9 Global Third-Party Controls Market, By Type, 2017 vs 2022 (USD Million)
Figure 10 Global IVD Quality Controls Market, By End User, 2017 vs 2022 (USD Million)
Figure 11 Global IVD Quality Controls Market, By Application, 2017 vs 2022 (USD Million)
Figure 12 IVD Quality Controls Market: Geographic Snapshot
Figure 13 Increasing Number of Accredited Laboratories is Driving the Adoption of IVD Quality Controls
Figure 14 Serum/Plasma-Based Controls to Dominate the Asia-Pacific IVD Quality Controls Market
Figure 15 U.S. Accounted for Largest Share of the IVD Quality Controls Market in 2016
Figure 16 IVD Quality Controls Market in Asia-Pacific to Grow at the Highest CAGR During the Forecast Period
Figure 17 Developing Markets to Register A Higher Growth Rate During the Forecast Period
Figure 18 IVD Quality Controls Market: Drivers, Restraints, Opportunities, & Challenges
Figure 19 Number of Laboratories Participating in EQA Programs in Brazil, 2010-2016
Figure 20 Quality Control Products Segment to Witness the Highest Growth During the Forecast Period
Figure 21 Molecular Diagnostics is Expected to Register the Highest CAGR During the Forecast Period
Figure 22 Third-Party Control Manufacturers Segment to Witness Highest Growth During the Forecast Period
Figure 23 Clinical Laboratories is the Fastest Growing End-User Segment of the IVD Quality Controls Market During the Forecast Period
Figure 24 North America to Dominate the IVD Quality Controls Market
Figure 25 North American IVD Quality Controls Market Snapshot
Figure 26 European IVD Quality Controls Market Snapshot
Figure 27 Asia-Pacific IVD Quality Controls Market Snapshot
Figure 28 Accredited Clinical Laboratories in Mexico: 2005-2015
Figure 29 Global in Vitro Diagnostics Quality Controls Market Share Analysis, By Key Player, 2016
Figure 30 Bio-Rad Laboratories, Inc.: Company Snapshot (2016)
Figure 31 Roche Diagnostics: Company Snapshot (2016)
Figure 32 Abbott Laboratories Inc.: Company Snapshot (2016)
Figure 33 Thermo Fisher Scientific, Inc.: Company Snapshot (2016)
Figure 34 Siemens AG: Company Snapshot (2016)
Figure 35 Sysmex Corporation: Company Snapshot
Figure 36 Danaher Corporation: Company Snapshot (2016)


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 4180
Published ON
Jul, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the In Vitro Diagnostics (IVD) Quality Control Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved